Companies

Instem Life Sciences Systems

Overview

Healthcare IT firm Instem Life Sciences Systems Instem provides software that helps pharma companies to automate processes and become more efficient. Staffordshire-based Instem joined Aim on 13 October and raised £9.15m gross (£8.33m net) at 175p a share. Existing shareholders raised £2.2m. The shares ended the first day’s trading at 185p, which valued Instem at £21.7m. Instem’s Provantis software is a leading application in the Early Development Safety Application (EDSA) market for early compounds. Instem recently launched Centrus, which integrates information for early drug development, management and reporting.

Sector: Health

News blog

• Instem Posted: 12/01/2015
• Instem Posted: 09/01/2014
• Instem Posted: 22/11/2013
• Instem Posted: 01/04/2013
• Instem Posted: 28/02/2013
• Instem Posted: 10/01/2013
• Instem Posted: 24/12/2012
• Instem Posted: 23/09/2012
• Instem Posted: 26/07/2012
• Instem Posted: 01/04/2012
• Instem Life Science Systems Posted: 09/01/2012
• Instem Life Science Systems Posted: 13/10/2010

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period